Krilogy Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-200
| Closed | -$2K | – | 185 |
|
|
2018
Q3 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 706 |
|
|
2018
Q2 | – | Sell |
-200
| Closed | -$1K | – | 198 |
|
|
2018
Q1 | $1K | Hold |
200
| – | – | ﹤0.01% | 723 |
|
|
2017
Q4 | $1K | Hold |
200
| – | – | ﹤0.01% | 726 |
|
|
2017
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 763 |
|
|
2017
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 687 |
|
|
2017
Q1 | $1K | Hold |
200
| – | – | ﹤0.01% | 671 |
|
|
2016
Q4 | $1K | Hold |
200
| – | – | ﹤0.01% | 671 |
|
|
2016
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 693 |
|
|
2016
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 705 |
|
|
2016
Q1 | $1K | Hold |
200
| – | – | ﹤0.01% | 634 |
|
|
2015
Q4 | $2K | Hold |
200
| – | – | ﹤0.01% | 375 |
|
|
2015
Q3 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 542 |
|